Adaptyv vs Isomorphic Labs

Side-by-side comparison of features, pricing, and ratings

Analysis reviewed Live tool data as of 2026-08-23
Cross-checked through our multi-step verification ·
Saved

At a glance

DimensionAdaptyvIsomorphic Labs
PricingFrom $149/protein (96 proteins, screening)Contact for partnership pricing
Target UsersAI-first protein design teams, academic labsLarge pharma companies
Primary OfferingAutomated wet-lab validation (binding, expression, thermostability)AI-driven drug design engine (predictive + generative)
Turnaround<3 weeks from sequence to dataVaries per partnership (software-only, no wet-lab)
API / IntegrationComprehensive API, Benchling Direct OrderingNot publicly accessible; closed partnerships
Latest News2026-05-13: LLM-designed binders (37/141 hits); 2026-04-01: Public API2026-05-12: Series B round; 2026-01-20: J&J collaboration

If you need rapid experimental validation of protein designs for AI model training, Adaptyv's <3-week automated lab with transparent per-protein pricing ($149/protein) is ready now. If you are a large pharma company seeking an exclusive AI drug discovery partnership, Isomorphic Labs' AlphaFold-based engine (backed by $600M+ funding and J&J/Novartis collaborations) is the right fit. For individual researchers or startups, Adaptyv is accessible; Isomorphic Labs is not.

Adaptyv
Adaptyv

Automated cloud lab that tests your protein designs in under 3 weeks.

Visit Website
Isomorphic Labs
Isomorphic Labs

AI-first drug discovery partner built on Nobel-winning AlphaFold.

Visit Website
Pricing
Paid
Contact Sales
Plans
$149/protein (includes 2 replicates)
Contact for pricing
Popularity
14 views
7.4k views
Skill Level
Intermediate
Advanced
API Available
Platforms
WebAPI
Categories
🧬 Drug Discovery & Life Sciences
🧬 Drug Discovery & Life Sciences
Features
Digital submission of protein sequences
Binding affinity screening assays
Expression yield measurements
Thermostability analysis
Turnaround under 3 weeks
Clean, labeled data packages for AI training
Comprehensive API for programmatic experiment creation
Query target catalogue via API
Real-time experiment progress tracking
Email notifications on experiment status
Integrated analysis tools with data export
Benchling Direct Ordering Partner integration
Per-protein pricing with cost estimates via API
Supports experiments up to 768 proteins with 2 replicates
Pre-validated target library or ship your own targets
Built on Nobel-winning AlphaFold system
Generative AI molecule design via Drug Design Engine
Predictive AI models for protein-ligand interactions
Digital biology simulation at scale
End-to-end drug discovery from target ID to lead optimization
Partnership model with Novartis and Johnson & Johnson
Drug metabolism and toxicity simulation
Bioresilience framework for pandemic preparedness
US operations established in 2025
Series B funding in February 2026
Max Jaderberg appointed as President
Dr. Ben Wolf appointed as Chief Medical Officer
Interdisciplinary team of ML and drug discovery experts
Integrations
Benchling

What real users say: Adaptyv vs Isomorphic Labs

Not marketing copy and not our opinion — a structured sweep of public discussion (reviews, forums, communities and video comments), showing what people praise and what they complain about for each tool.

Adaptyv

4 mentions across 1 sources · 65% positive

Hacker News

What users praise

  • Under 3-week turnaround from sequence to data.
  • Transparent per-protein pricing; cost estimates via API.
  • All-in-one platform for ordering, tracking, analyzing results.
  • Clean, labeled data packages ideal for AI model training.

What frustrates them

  • Very few independent user reviews to validate claims.
  • Automated assays may lack flexibility for custom protocols.
  • No publicly available pricing tiers – per-protein only.
  • Limited to binding, expression, and thermostability assays.

Researched Jul 3, 2026

Isomorphic Labs

48 mentions across 3 sources · 82% positive

Hacker News, YouTube, Lemmy

What users praise

  • Built on the Nobel-winning AlphaFold, giving it instant credibility in structural biology.
  • Drug Design Engine extends beyond structure to generative molecule design, promising novel chemistry.
  • Deep partnerships with Novartis and J&J, with potential billions in royalties.
  • Interdisciplinary team of top ML and drug discovery experts, ensuring depth of expertise.

What frustrates them

  • Not accessible to individual researchers or small biotech due to partnership model only.
  • Proprietary nature of parts of its tech limits community scrutiny and independent validation.
  • CASP16 results suggest AlphaFold 3-based models aren't always better than older methods for protein-ligand interactions.
  • No marketed drugs yet; outcomes remain uncertain with royalties tied to long timelines.

Researched Aug 18, 2026

Who should pick which

  • Solo founder building AI protein design models
    Pick: Adaptyv

    Transparent per-protein pricing ($149/protein) and a public API to rapidly validate designs, with results in <3 weeks. Isomorphic Labs is inaccessible to individuals.

  • Academic lab needing high-throughput binder screening
    Pick: Adaptyv

    Direct Benchling integration and automated wet-lab for binding/thermostability assays with clean data suitable for model training. Turnaround <3 weeks fits academic cycles.

  • Large pharma company launching a drug development program
    Pick: Isomorphic Labs

    Exclusive partnership model with a Nobel Prize-winning AI engine (AlphaFold), $600M funding, and established collaborations with Novartis and J&J.

  • Autonomous AI agent for protein design
    Pick: Adaptyv

    Adaptyv's comprehensive API enables programmatic experiment creation and data retrieval, directly supporting autonomous agents. Isomorphic Labs offers no public API.

  • Team needing custom assay development beyond binding/thermostability
    Pick: Isomorphic Labs

    Adaptyv explicitly does not support custom assays beyond binding, expression, or thermostability. Isomorphic Labs' partnership model could potentially include bespoke computational solutions, but no wet-lab.

Frequently Asked Questions

Adaptyv vs Isomorphic Labs: which should you choose?

If you need rapid experimental validation of protein designs for AI model training, Adaptyv's <3-week automated lab with transparent per-protein pricing ($149/protein) is ready now. If you are a large pharma company seeking an exclusive AI drug discovery partnership, Isomorphic Labs' AlphaFold-based engine (backed by $600M+ funding and J&J/Novartis collaborations) is the right fit. For individual researchers or startups, Adaptyv is accessible; Isomorphic Labs is not.

What is the minimum order size for Adaptyv?

Adaptyv's static facts indicate pricing starts at 96 proteins (screening resolution). They support up to 768 proteins per experiment.

Does Isomorphic Labs offer any pay-per-use or API access?

No. Isomorphic Labs operates solely through pharma partnerships and does not provide a public API, software, or per-use pricing.

Can I use Adaptyv only for binding assays?

Yes. Adaptyv offers binding, expression, and thermostability assays. It does not support cell-based, enzymatic, or in vivo assays.

Is Isomorphic Labs a spinout of DeepMind?

Yes. It was spun out of DeepMind and builds on the Nobel Prize-winning AlphaFold system.

What was Isomorphic Labs' latest funding round?

According to news from 2026-05-12, it closed a Series B investment round (amount undisclosed). In 2025-03-31, it raised a $600M external investment round.

Does Adaptyv integrate with Benchling?

Yes. According to news from 2026-05-06, Adaptyv is integrated into Benchling's Direct Ordering Partners.

Who are Isomorphic Labs' pharma partners?

Static facts and news (2026-01-20) list Novartis and Johnson & Johnson as collaborators.

What is the turnaround time for Adaptyv?

Adaptyv guarantees results in under three weeks from sequence submission.

More Adaptyv or Isomorphic Labs comparisons

Explore each tool further

Browse these categories

Still deciding? Get the weekly AI tools brief

One email a week — new tools, honest comparisons, no spam.

Last reviewed: July 3, 2026